Showing results (21-30 of 293) with videos related to
Sort By:
Pageof 30
International Journal of Technology Assessment in Health Care|June 17, 2009
Health technology assessment in CanadaRenaldo N Battista, Brigitte Côté, Matthew J Hodge, et al.Health Economics|March 3, 2026
Guidance or Misdirection? Unpacking the Role of Feedback in Health Preference AssessmentsMesfin G Genie, Shelby D Reed, Semra OzdemirValue in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 27, 2025
Means Can Be Deceiving: Comparing and Contrasting Risk Tolerance Estimates From a Discrete-Choice Experiment and a Threshold Technique ExerciseJessie Sutphin, Matthew J Wallace, Shelby D Reed, et al.Nephrology (Carlton, Vic.)|June 4, 2008
Cost-effectiveness of the oral adsorbent AST-120 versus placebo for chronic kidney diseaseTomohiko Takahashi, Shelby D Reed, Kevin A SchulmanPhysical Therapy|June 27, 2015
Out-of-Pocket Spending for Ambulatory Physical Therapy Services From 2008 to 2012: National Panel SurveyJulia Chevan, Daniel L Riddle, Shelby D ReedValue in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 8, 2012
Cost-effectiveness of sensor-augmented pump therapy in adults with type 1 diabetes in the United StatesShital Kamble, Kevin A Schulman, Shelby D ReedInternational Journal of Technology Assessment in Health Care|May 29, 2019
Use of Real-World Data Sources for Canadian Drug Pricing and Reimbursement Decisions: Stakeholder Views and Lessons for Other CountriesDon Husereau, Edward Nason, Tarun Ahuja, et al.Journal of the National Comprehensive Cancer Network : JNCCN|March 14, 2019
Chemotherapy Costs and 21-Gene Recurrence Score Genomic Testing Among Medicare Beneficiaries With Early-Stage Breast Cancer, 2005 to 2011Michaela A Dinan, Lauren E Wilson, Shelby D ReedHealth Affairs (Project Hope)|September 13, 2006
How changes in drug-safety regulations affect the way drug and biotech companies invest in innovationShelby D Reed, Robert M Califf, Kevin A SchulmanJournal of General Internal Medicine|January 10, 2008
Economic implications of potential changes to regulatory and reimbursement policies for medical devicesShelby D Reed, Alisa M Shea, Kevin A SchulmanPageof 30